Vincent Couallier

Documents

Publications

1051684

	Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial Erwann Loret , Albert Darque , Elisabeth Jouve , Elvenn A Loret , Corinne Nicolino-Brunet Retrovirology, 2016, 13 (1), ⟨10.1186/s12977-016-0251-3⟩ Article dans une revue hal-02077548v1